Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Bills face urgent trade deadline after key injury, as teams across the NFL seek to bolster rosters before the cutoff.
Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
Bills face urgent trade deadline after key injury, as teams across the NFL seek to bolster rosters before the cutoff.